Tekla Capital Management as of March 31, 2016
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 140 positions in its portfolio as reported in the March 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 9.1 | $214M | 2.3M | 91.86 | |
| Celgene Corporation | 7.4 | $175M | 1.7M | 100.09 | |
| Biogen Idec (BIIB) | 5.0 | $117M | 451k | 260.32 | |
| Allergan | 4.7 | $110M | 410k | 268.03 | |
| Alexion Pharmaceuticals | 3.8 | $89M | 637k | 139.22 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $82M | 1.0M | 79.49 | |
| Incyte Corporation (INCY) | 3.0 | $69M | 957k | 72.47 | |
| Illumina (ILMN) | 2.4 | $57M | 349k | 162.11 | |
| Regeneron Pharmaceuticals (REGN) | 2.4 | $56M | 154k | 360.44 | |
| Pfizer (PFE) | 2.3 | $54M | 1.8M | 29.64 | |
| UnitedHealth (UNH) | 2.2 | $53M | 409k | 128.90 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $49M | 596k | 82.48 | |
| Amgen (AMGN) | 2.0 | $48M | 322k | 149.93 | |
| Medtronic (MDT) | 1.8 | $42M | 557k | 75.00 | |
| Johnson & Johnson (JNJ) | 1.7 | $41M | 375k | 108.20 | |
| Teva Pharmaceutical Industries (TEVA) | 1.5 | $36M | 672k | 53.51 | |
| Merck & Co (MRK) | 1.5 | $36M | 681k | 52.91 | |
| Shire | 1.5 | $35M | 202k | 171.90 | |
| Medivation | 1.3 | $31M | 667k | 45.98 | |
| Eli Lilly & Co. (LLY) | 1.3 | $30M | 417k | 72.01 | |
| Mylan Nv | 1.2 | $29M | 618k | 46.35 | |
| Agilent Technologies Inc C ommon (A) | 1.2 | $28M | 714k | 39.85 | |
| Hca Holdings (HCA) | 1.1 | $26M | 335k | 78.05 | |
| Humana (HUM) | 1.0 | $24M | 129k | 182.95 | |
| Ventas (VTR) | 1.0 | $23M | 369k | 62.96 | |
| Jazz Pharmaceuticals (JAZZ) | 1.0 | $23M | 179k | 130.55 | |
| Physicians Realty Trust | 1.0 | $23M | 1.2M | 18.58 | |
| Molina Healthcare (MOH) | 0.9 | $22M | 348k | 64.49 | |
| Medical Properties Trust (MPW) | 0.9 | $20M | 1.6M | 12.98 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $20M | 715k | 27.96 | |
| Alkermes (ALKS) | 0.8 | $20M | 582k | 34.19 | |
| Medicines Company | 0.8 | $18M | 564k | 31.77 | |
| Universal Health Services (UHS) | 0.7 | $17M | 135k | 124.72 | |
| Novo Nordisk A/S (NVO) | 0.7 | $16M | 295k | 54.19 | |
| SPDR S&P Biotech (XBI) | 0.7 | $15M | 294k | 51.66 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.6 | $15M | 58k | 260.81 | |
| Omega Healthcare Investors (OHI) | 0.6 | $15M | 413k | 35.30 | |
| St. Jude Medical | 0.6 | $14M | 256k | 55.00 | |
| Mallinckrodt Pub | 0.6 | $14M | 224k | 61.28 | |
| Stryker Corporation (SYK) | 0.6 | $13M | 124k | 107.29 | |
| Baxter International (BAX) | 0.6 | $13M | 320k | 41.08 | |
| Bristol Myers Squibb (BMY) | 0.6 | $13M | 203k | 63.88 | |
| McKesson Corporation (MCK) | 0.6 | $13M | 83k | 157.25 | |
| Horizon Pharma | 0.5 | $12M | 750k | 16.57 | |
| Welltower Inc 6.50% pfd prepet | 0.5 | $12M | 200k | 62.10 | |
| Thermo Fisher Scientific (TMO) | 0.5 | $12M | 86k | 141.59 | |
| Sanofi-Aventis SA (SNY) | 0.5 | $12M | 305k | 40.16 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $12M | 312k | 39.55 | |
| Senior Housing Properties Trust | 0.5 | $12M | 671k | 17.89 | |
| Corsicanto Ltd conv bnd | 0.5 | $12M | 15M | 0.80 | |
| GlaxoSmithKline | 0.5 | $12M | 285k | 40.55 | |
| Paratek Pharmaceuticals | 0.5 | $12M | 763k | 15.17 | |
| Cepheid | 0.5 | $11M | 334k | 33.36 | |
| Zimmer Holdings (ZBH) | 0.5 | $11M | 102k | 106.63 | |
| LTC Properties (LTC) | 0.5 | $11M | 237k | 45.24 | |
| Ardelyx (ARDX) | 0.5 | $11M | 1.4M | 7.77 | |
| IDEXX Laboratories (IDXX) | 0.4 | $10M | 132k | 78.32 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $10M | 93k | 111.43 | |
| AstraZeneca (AZN) | 0.4 | $10M | 356k | 28.16 | |
| Sabra Health Care REIT (SBRA) | 0.4 | $9.2M | 456k | 20.09 | |
| Cepheid conv | 0.4 | $8.9M | 10M | 0.89 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $8.6M | 138k | 62.77 | |
| Icon (ICLR) | 0.4 | $8.6M | 115k | 75.10 | |
| Cellectis S A (CLLS) | 0.4 | $8.5M | 310k | 27.50 | |
| Natera (NTRA) | 0.4 | $8.4M | 882k | 9.52 | |
| Endo International | 0.3 | $8.1M | 286k | 28.15 | |
| Puma Biotechnology (PBYI) | 0.3 | $7.6M | 260k | 29.37 | |
| Centene Corporation (CNC) | 0.3 | $7.4M | 120k | 61.57 | |
| Pieris Pharmaceuticals | 0.3 | $7.3M | 3.8M | 1.90 | |
| Novartis (NVS) | 0.3 | $6.7M | 93k | 72.44 | |
| Flamel Technologies | 0.3 | $6.9M | 624k | 11.04 | |
| Juno Therapeutics | 0.3 | $6.9M | 182k | 38.09 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.3 | $6.6M | 13M | 0.51 | |
| Foamix Pharmaceuticals | 0.3 | $6.3M | 966k | 6.52 | |
| Supernus Pharmaceuticals note 7.500 5/0 | 0.3 | $6.0M | 2.0M | 3.01 | |
| Healthcare Realty Trust Incorporated | 0.2 | $5.8M | 187k | 30.89 | |
| Akorn | 0.2 | $5.8M | 245k | 23.53 | |
| Anacor Pharmaceuticals In | 0.2 | $5.9M | 110k | 53.45 | |
| Community Health Systems (CYH) | 0.2 | $5.6M | 305k | 18.51 | |
| Exelixis (EXEL) | 0.2 | $5.6M | 1.4M | 4.00 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $5.6M | 88k | 63.31 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $5.2M | 188k | 27.80 | |
| Healthcare Tr Amer Inc cl a | 0.2 | $5.2M | 178k | 29.42 | |
| Epizyme | 0.2 | $4.8M | 400k | 12.12 | |
| Endologix | 0.2 | $4.6M | 551k | 8.36 | |
| Merrimack Pharmaceuticals In | 0.2 | $4.8M | 570k | 8.37 | |
| Tenet Healthcare Corporation (THC) | 0.2 | $4.8M | 165k | 28.93 | |
| Perrigo Company (PRGO) | 0.2 | $4.8M | 37k | 127.94 | |
| Sage Therapeutics (SAGE) | 0.2 | $4.7M | 147k | 32.06 | |
| Dynavax Technologies (DVAX) | 0.2 | $4.6M | 241k | 19.24 | |
| Allergan Plc pfd conv ser a | 0.2 | $4.6M | 5.0k | 919.20 | |
| Karyopharm Therapeutics (KPTI) | 0.2 | $4.5M | 500k | 8.92 | |
| Retrophin | 0.2 | $4.5M | 330k | 13.66 | |
| Valeant Pharmaceuticals Int | 0.2 | $4.2M | 158k | 26.30 | |
| Heron Therapeutics (HRTX) | 0.2 | $4.2M | 219k | 18.99 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $4.2M | 328k | 12.90 | |
| Impax Laboratories | 0.2 | $4.0M | 124k | 32.02 | |
| Accelr8 Technology | 0.2 | $3.8M | 265k | 14.37 | |
| Sagent Pharmaceuticals | 0.1 | $3.5M | 287k | 12.17 | |
| Inotek Pharmaceuticals | 0.1 | $3.6M | 487k | 7.40 | |
| Beigene | 0.1 | $3.4M | 117k | 29.31 | |
| Auris Med Hldg | 0.1 | $3.0M | 834k | 3.64 | |
| DepoMed | 0.1 | $2.8M | 200k | 13.93 | |
| Uniqure Nv (QURE) | 0.1 | $2.9M | 241k | 11.88 | |
| Nevro (NVRO) | 0.1 | $2.8M | 50k | 56.27 | |
| Arca Biopharma | 0.1 | $2.8M | 811k | 3.43 | |
| Immunomedics Inc note 4.750% 2/1 | 0.1 | $2.8M | 4.0M | 0.70 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.1 | $2.6M | 166k | 15.47 | |
| Celator Pharmaceuticals | 0.1 | $2.6M | 236k | 11.03 | |
| Allscripts Healthcare Solutions (MDRX) | 0.1 | $2.3M | 174k | 13.21 | |
| Insmed (INSM) | 0.1 | $2.3M | 179k | 12.67 | |
| Forward Pharma A/s | 0.1 | $2.3M | 137k | 17.00 | |
| Flex Pharma | 0.1 | $2.3M | 213k | 10.97 | |
| Lexicon Pharmaceuticals (LXRX) | 0.1 | $2.4M | 198k | 11.95 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $2.4M | 297k | 8.13 | |
| Care Cap Properties | 0.1 | $2.3M | 84k | 26.84 | |
| Amicus Therapeutics (FOLD) | 0.1 | $2.2M | 258k | 8.45 | |
| Bluebird Bio (BLUE) | 0.1 | $2.1M | 49k | 42.50 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $2.2M | 1.5M | 1.48 | |
| Dbv Technologies S A | 0.1 | $2.1M | 66k | 32.55 | |
| Cynapsus Therapeutics | 0.1 | $2.1M | 180k | 11.90 | |
| Novavax | 0.1 | $1.8M | 358k | 5.16 | |
| Halozyme Therapeutics (HALO) | 0.1 | $1.9M | 200k | 9.47 | |
| Kite Pharma | 0.1 | $1.9M | 41k | 45.90 | |
| Esperion Therapeutics (ESPR) | 0.1 | $1.7M | 103k | 16.91 | |
| Chimerix (CMRX) | 0.1 | $1.6M | 309k | 5.11 | |
| Momenta Pharmaceuticals | 0.1 | $1.4M | 154k | 9.24 | |
| Alliqua | 0.1 | $1.4M | 1.7M | 0.82 | |
| Affimed Therapeutics B V | 0.1 | $1.1M | 294k | 3.74 | |
| Tetraphase Pharmaceuticals | 0.0 | $891k | 192k | 4.63 | |
| Galapagos Nv- (GLPG) | 0.0 | $836k | 20k | 41.80 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $921k | 73k | 12.70 | |
| Revance Therapeutics (RVNC) | 0.0 | $786k | 45k | 17.47 | |
| Celldex Therapeutics | 0.0 | $400k | 106k | 3.78 | |
| GenMark Diagnostics | 0.0 | $492k | 93k | 5.27 | |
| Bellicum Pharma | 0.0 | $561k | 60k | 9.35 | |
| Xencor (XNCR) | 0.0 | $268k | 20k | 13.40 | |
| Rmr Group Inc cl a (RMR) | 0.0 | $186k | 7.4k | 25.00 | |
| Abbvie (ABBV) | 0.0 | $9.0k | 156.00 | 57.69 | |
| Zafgen | 0.0 | $89k | 13k | 6.69 |
